Clinical Trial Update: DMCRN-02-001: Assessing Pediatric Endpoints in DM1

View source ↗

Summary

A clinical trial (DMCRN-02-001) assessing pediatric endpoints in congenital myotonic dystrophy (DM1) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Myotonic Dystrophy
• Myotonic Dystrophy Type

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Congenital Myotonic Dystrophy, CDM | Status: RECRUITING